Synthetic substrate analog inhibitors for the study of structure-activity relationships in proteases
Fittkau, S.
Die Pharmazie 32(8-9): 445-448
1977
ISSN/ISBN: 0031-7144 PMID: 339234 Document Number: 122099
Document emailed within 1 workday
Related Documents
Walsmann, P.; Markwardt, F.; Stürzebecher, J.; Vieweg, H.; Wagner, G. 1979: Synthetic inhibitors of serine proteinases. Part 21: Studies on the structure-activity relationships in bisamidines Die Pharmazie 34(12): 837-839Stürzebecher, J.; Markwardt, F.; Wagner, G.; Walsmann, P. 1976: Synthetic inhibitors of serine proteinases. 13. Quantitative structure-activity relationship for inhibition of trypsin and thrombin by 4-amidinophenyl compounds with a ketone structure Acta Biologica et Medica Germanica 35(12): 1665-1676
Bowden, K.; Harris, N.V.; Watson, C.A. 1993: Structure-activity relationships of dihydrofolate reductase inhibitors Journal of ChemoTherapy 5(6): 377-388
Marastoni, M.; Bortolotti, F.; Salvadori, S.; Tomatis, R. 1998: Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit Arzneimittel-Forschung 48(6): 709-712
Fossa, P.; Boggia, R.; Lo Presti, E.; Mosti, L.; Dorigo, P.; Floreani, M. 1997: Inotropic Agents. Synthesis and Structure-Activity Relationships of new Milrinone Related Camp Pde Iii Inhibitors Farmaco 52(8-9): 523-530
Claeson, G. 1994: Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 5(3): 411-436
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Beránek, J. 1986: A study on structure-activity relationships of nucleoside analogues Drugs under Experimental and Clinical Research 12(4): 355-367
Heine, H. 1984: Proteases - proteases inhibitors: a local cellular information system Advances in Experimental Medicine and Biology 167: 121-127
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Cellai, L.; Cerrini, S.; Segre, A.; Battistoni, C.; Cossu, G.; Mattogno, G.; Brufani, M.; Marchi, E. 1985: A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR Molecular Pharmacology 27(1): 103-108
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Agresti, A.; Buffoni, F.; Kaufman, J.J.; Petrongolo, C. 1980: Structure--activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water Molecular Pharmacology 18(3): 461-467
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Kinder, D.H.; Elstad, C.A.; Meadows, G.G.; Ames, M.M. 1992: Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivo Invasion and Metastasis 12(5-6): 309-319
Prabhakar, Y.S.; Gupta, S.P. 1985: Structure-Activity relationship study on angiotensin-converting enzyme inhibitors--investigation of hydrophobic interaction in inhibition mechanism Indian Journal of Biochemistry and Biophysics 22(5): 318-320
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Richards, R.K. 1980: Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity Archives Internationales de Pharmacodynamie et de Therapie 244(1): 107-112
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018